NCT03618316View on ClinicalTrials.gov

Effect of Cimetidine on the PK of Imeglimin

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

July 21, 2018

Study Completion Date

July 27, 2018

Conditions

Healthy

Interventions

DRUG

Imeglimin

2 singles oral doses of imeglimin 1,500 mg (one at day 1 and one at day 8)

DRUG

Cimetidine

400 mg of cimetidine bid from Day 5 to Day 10

Trial Locations (1)

Unknown

Hammersmith Medicines Research (HMR), London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Poxel SA

INDUSTRY